Cargando…

Asbestos Burden Predicts Survival in Pleural Mesothelioma

BACKGROUND: Malignant pleural mesothelioma (MPM) is a rapidly fatal asbestos-associated malignancy with a median survival time of < 1 year following diagnosis. Treatment strategy is determined in part using known prognostic factors. OBJECTIVE: The aim of this study was to examine the relationship...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christensen, Brock C., Godleski, John J., Roelofs, Cora R., Longacker, Jennifer L., Bueno, Raphael, Sugarbaker, David J., Marsit, Carmen J., Nelson, Heather H., Kelsey, Karl T.
Formato:	Texto
Lenguaje:	English
Publicado:	National Institute of Environmental Health Sciences 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430226/ https://www.ncbi.nlm.nih.gov/pubmed/18560526 http://dx.doi.org/10.1289/ehp.11151

Ejemplares similares

Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma
por: Christensen, Brock C., et al.
Publicado: (2008)

Cytomegalovirus infection in malignant pleural mesothelioma
por: Hunter-Schlichting, DeVon, et al.
Publicado: (2021)

Genes Associated With Prognosis After Surgery For Malignant Pleural Mesothelioma Promote Tumor Cell Survival In Vitro
por: Gordon, Gavin J, et al.
Publicado: (2011)

Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden
por: Gilham, Clare, et al.
Publicado: (2016)

An Overview of Asbestos and Malignant Pleural Mesothelioma: An Iranian Perspective
por: Emami, Habib, et al.
Publicado: (2017)

Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos
por: Magnani, C, et al.
Publicado: (2000)

Malignant Pleural and Peritoneal Mesothelioma Consequential to Brief Indirect Asbestos Exposure
por: Singhal, Bharati, et al.
Publicado: (2014)

Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma
por: Farahmand, Pooyeh, et al.
Publicado: (2023)

Differentially expressed alternatively spliced genes in Malignant Pleural Mesothelioma identified using massively parallel transcriptome sequencing
por: Dong, Lingsheng, et al.
Publicado: (2009)

Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden
por: Järvholm, Bengt, et al.
Publicado: (2015)

Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use
por: Oddone, Enrico, et al.
Publicado: (2020)

MicroRNA and mRNA Features of Malignant Pleural Mesothelioma and Benign Asbestos-Related Pleural Effusion
por: Ak, Guntulu, et al.
Publicado: (2015)

Chrysotile fibers in tissue adjacent to laryngeal squamous cell carcinoma in cases with a history of occupational asbestos exposure
por: Wronkiewicz, Stephanie K., et al.
Publicado: (2019)

Estimating the asbestos-related lung cancer burden from mesothelioma mortality
por: McCormack, V, et al.
Publicado: (2012)

Estimating the asbestos-related lung cancer burden from mesothelioma mortality
por: McCormack, V, et al.
Publicado: (2014)

Chrysotile Asbestos and Mesothelioma
por: Lemen, Richard A.
Publicado: (2010)

Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden
por: Hemminki, Kari, et al.
Publicado: (2021)

Immune Microenvironment and Genetics in Malignant Pleural Mesothelioma
por: Wadowski, Benjamin, et al.
Publicado: (2021)

Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040
por: Oddone, Enrico, et al.
Publicado: (2021)

Asbestos Exposure in Patients with Malignant Pleural Mesothelioma included in the PRIMATE Study, Lombardy, Italy
por: Spinazzè, Andrea, et al.
Publicado: (2022)

Pleurectomy decortication is the preferred surgical procedure in pleural mesothelioma
por: Lapidot, Moshe, et al.
Publicado: (2023)

Asbestos, mesothelioma and the legacy of shipbuilding in Belfast
por: Morrison, Patrick J
Publicado: (2008)

Mesotheliomas in rats following inoculation with asbestos.
por: Wagner, J. C., et al.
Publicado: (1969)

Asbestos and Mesothelioma: A Comment
por: Jargin, Sergei V.
Publicado: (2018)

Reply: Comment on ‘Estimating the asbestos-related lung cancer burden from mesothelioma mortality'
por: McCormack, V, et al.
Publicado: (2013)

Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.
por: Tiainen, M., et al.
Publicado: (1989)

Treatments affecting the rate of asbestos-induced mesotheliomas.
por: Wagner, J. C., et al.
Publicado: (1980)

Must countries shoulder the burden of mesothelioma to ban asbestos? A global assessment
por: Chimed-Ochir, Odgerel, et al.
Publicado: (2022)

Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma
por: Gill, Ritu R, et al.
Publicado: (2017)

A Rare Case of Malignant Pleural Mesothelioma in a Young Healthy Male Without Asbestos Exposure
por: Khatib, Sohaib, et al.
Publicado: (2021)

Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review
por: Zolondick, Alicia A., et al.
Publicado: (2021)

Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma
por: Lee, Hyun-Sung, et al.
Publicado: (2018)

Thymectomy and asbestos-induced mesotheliomas in rats.
por: Wagner, M. M.
Publicado: (1979)

Asbestos Exposure and the Mesothelioma Incidence in Poland
por: Krówczyńska, Małgorzata, et al.
Publicado: (2018)

Software for Apportionment of Asbestos-Related Mesotheliomas
por: Ross, Robert M.
Publicado: (2016)

Asbestos-related pleural disease
por: Geller, Stephen A., et al.
Publicado: (2013)

Aging and Environmental Exposures Alter Tissue-Specific DNA Methylation Dependent upon CpG Island Context
por: Christensen, Brock C., et al.
Publicado: (2009)

The economic burden of lung cancer and mesothelioma due to occupational and para-occupational asbestos exposure
por: Tompa, Emile, et al.
Publicado: (2017)

A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases
por: Visonà, S. D., et al.
Publicado: (2023)

Serum Proteomics and Plasma Fibulin-3 in Differentiation of Mesothelioma From Asbestos-Exposed Controls and Patients With Other Pleural Diseases
por: Tsim, Selina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_94f636rcujob5h8defs29ulgaa